WHO Alert at Mpox – MonkeyPox Disease
WHO – World Health Organization had been declare the Mpox – MonkeyPox disease as a global emergency due to widespread from Africa to worldwide.
What is MonkeyPox Disease?
MonkeyPox is also known as Mpox in short form. It is a viral disease caused by MonkeyPox Virus and belongs to variola virus of Orthopoxvirus genus. This virus group also belongs to smallpox and cowpox viruses.
Mpox – MonkeyPox Disease Origin
Mpox – MonkeyPox disease origin is central and western Africa. This disease now spreading worldwide.
Transmission of Mpox – Monkeypox Disease
- Animal-to-Human: Monkeypox is a zoonotic disease, which means that the virus occurs naturally in animals and has been known to cause infection in humans. It is approximately linked to rodents and primates throughout Central and West Africa.
- Human to Human: It proves to be also highly H2H transmissible by the spread between humans with direct areas of close contact (Face-to-Face) transmission allows Human-To-Human an individual infected shows or brings into touch with other Respiratory droplets from sneezing symptoms injectant and can easily transmit fomites bedding.
Countries Effected by Mpox – MonkeyPox Disease
According to UNO many countries are affected due to Monkey Pox disease. List of these countries are given below:
- Democratic Republic of the Congo (DRC)
- Burundi
- Kenya
- Rwanda
- Uganda
Mpox – MonkeyPox Disease Early Symptoms
Mpox – MonkeyPox disease have very common symptoms appeared in infected person. Some of them are given below:
- Headache
- Fever
- Chills
- Exhaustion
- Muscle aches and backache
- Swollen lymph nodes
Mpox – MonkeyPox Disease Recent Outbreak
In the past years, cases outside Africa have been reported in some European and North American countries, and public health responses have been taken to contain the spread of this disease. It also made global news with a massive global outbreak in 2022 and now in 2024.
Mpox – MonkeyPox Disease Prevention
The smallpox vaccine confers protection against monkeypox. Other preventive measures are avoiding contact with infected animals and following good hygiene.
Treatment of Mpox – MonkeyPox Disease
Although typically self-limiting, monkeypox can also cause severe complications, particularly in children or persons who are immunocompromised. Treatment is ordinarily supportive, but antiviral medications, like tecovirimat, licensed for treating smallpox, may be given in severe cases.
WHO Treatment Guidelines for Mpox – MonkeyPox Disease
Treatment for pox (monkeypox) patients is supportive and based on the symptoms. Some therapeutics that might be useful for treating pox are still in development and testing.
Prevention and control of pox rely on raising awareness among communities and health workers to prevent and adequately manage human infection.
Direct contact with infected people or materials must be avoided. Gloves and other forms of personal protective gear are important not only for the staff involved in caring for the sick, whether at home or in a health care facility.
For primary transmission of this Mpox illness, stay away from contact with infected or dead animals, and cook any foods containing animal flesh or parts well before eating.
It spreads more easily among humans today because routine smallpox vaccination is no longer performed, providing cross-protection since the virus has been eradicated. In the past, smallpox vaccination using first-generation vaccinia virus-based smallpox vaccine was proven to be 85% effective in preventing pox. Members of families and communities, health workers, and laboratory personnel vaccinated against smallpox in childhood are likely still able to confer some immunity against the disease pox.
Many years of hard work have resulted in the development of newer and safer vaccines for smallpox, which could also be used in the eradication of pox. Three vaccines for pox are currently available, but they are limited in quantity, and some countries are already recommending the use of one of these three vaccines for individuals at risk.
